{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:58:53Z","timestamp":1792803533114,"version":"4.5.0"},"reference-count":53,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical University of Lodz","award":["503\/6-006-05"],"award-info":[{"award-number":["503\/6-006-05"]}],"id":[{"id":"https:\/\/ror.org\/02t4ekc95","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Medical University of Lodz","award":["UK\/US\/06\/2022\/01\/00004"],"award-info":[{"award-number":["UK\/US\/06\/2022\/01\/00004"]}],"id":[{"id":"https:\/\/ror.org\/02t4ekc95","id-type":"ROR","asserted-by":"crossref"}]},{"name":"ALAB Laboratories","award":["503\/6-006-05"],"award-info":[{"award-number":["503\/6-006-05"]}]},{"name":"ALAB Laboratories","award":["UK\/US\/06\/2022\/01\/00004"],"award-info":[{"award-number":["UK\/US\/06\/2022\/01\/00004"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Background: The mixed type of irritable bowel syndrome (IBS-M) is characterized by recurrent constipation and diarrhea. The cause of the variability of these symptoms is not sufficiently understood. The aim of this study was to perform metagenomic and metabolic assessment of the gut microbiome in constipation and diarrheal period of IBS-M. Methods: This study included 30 women, aged 28\u201347 years old, with the symptoms which aligned with those of IBS-M, according to the Rome IV Criteria. Results: In both periods of the disease, the dysbiosis index (DI), the Shannon diversity index (SDI), the hydrogen\u2013methane and ammonia breath tests, as well as the selected bacterial metabolites (-p-hydroxyphenyl acetic acid (HPA), 3-indoxyl sulfate (Indican, 3-IS)), and hippuric acid (A) in urine, were determined. The dysbiosis index (DI) in the period of constipation was 3.73 \u00b1 0.90 points, and in the diarrheal period it did not change significantly 3.93 \u00b1 0.75 points (p &gt; 0.05). During the diarrheal period, the diversity of bacteria increases from 2.16 \u00b1 0.59 to 2.74 \u00b1 0.50 points on the Shannon dietary index (p &lt; 0.001). The gut microbiome profile also changed, especially during the diarrheal period where an abundance of Bifidobacterium spp. and Lactobacillus spp. decreased significantly. In addition, during this period, the levels of hydrogen and ammonia in breath air increased, while the methane level decreased. The differences also concern the results of urinary metabolites, especially related to hippuric acid and indican. During the diarrheal period, the levels of hydrogen and ammonia ions increased, while the methane level decreased. The differences also concern the results of urinary metabolites, especially related to hippuric acid and indican. Conclusions: In patients with IBS-M, periodic changes in the profile and metabolism of the gut microbiome occur, which coexist with recurrent symptoms such as constipation and diarrhea.<\/jats:p>","DOI":"10.3390\/biomedicines13030652","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T07:05:46Z","timestamp":1741331146000},"page":"652","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Periodic Changes in the Gut Microbiome in Women with the Mixed Type of Irritable Bowel Syndrome"],"prefix":"10.3390","volume":"13","author":[{"given":"Aleksandra","family":"Kaczka","sequence":"first","affiliation":[{"name":"Department of Clinical Nutrition and Gastroenterological Diagnostics, Medical University of Lodz, 90-647 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"B\u0142o\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Clinical Nutrition and Gastroenterological Diagnostics, Medical University of Lodz, 90-647 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1620-4775","authenticated-orcid":false,"given":"Cezary","family":"Chojnacki","sequence":"additional","affiliation":[{"name":"Department of Clinical Nutrition and Gastroenterological Diagnostics, Medical University of Lodz, 90-647 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8288-3721","authenticated-orcid":false,"given":"Anita","family":"G\u0105siorowska","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Medical University of Lodz, 92-213 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9539-9584","authenticated-orcid":false,"given":"Janusz","family":"B\u0142asiak","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Collegium Medicum, Mazovian Academy in Plock, 09-402 Plock, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2300-7339","authenticated-orcid":false,"given":"Tomasz","family":"Pop\u0142awski","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Microbiology and Biochemistry, Medical University of Lodz, 92-215 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8766-7868","authenticated-orcid":false,"given":"Jan","family":"Chojnacki","sequence":"additional","affiliation":[{"name":"Department of Clinical Nutrition and Gastroenterological Diagnostics, Medical University of Lodz, 90-647 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Lacy, B.E., and Patel, N.K. (2017). Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome. J. Clin. Med., 6.","DOI":"10.3390\/jcm6110099"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/ajg.2011.358","article-title":"Patients Show Frequent Fluctuations between Loose\/Watery and Hard\/Lumpy Stools: Implications for treatment","volume":"107","author":"Palsson","year":"2012","journal-title":"Am. J. Gastroenterol."},{"key":"ref_3","first-page":"220","article-title":"Patterns of alternation in irritable bowel syndrome","volume":"89","author":"Chira","year":"2016","journal-title":"Clujul Med."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Wang, K., Liu, H., Han, L., Kang, Z., Liang, L., Jianag, S., Meng, N., Chen, P., Xu, Q., and Wu, Q. (2022). Factors Related to Irritable Bowel Syndrome and Differences Among Subtypes: A Cross-Sectional Study in the UK Biobank. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.905564"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1365-2036.2006.02858.x","article-title":"Review article: Intestinal serotonin signalling in irritable bowel syndrome","volume":"23","author":"Mawe","year":"2006","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cca.2009.01.028","article-title":"Role of serotonin in gastrointestinal motility and irritable bowel syndrome","volume":"403","author":"Sikander","year":"2009","journal-title":"Clin. Chim. Acta"},{"key":"ref_7","first-page":"14","article-title":"Non-neuronal dopamine in the gastrointestinal system","volume":"26","author":"Mezey","year":"1999","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_8","first-page":"817","article-title":"Alterd Dopamine Signalling in Chronic Epigastric Pain Syndrome","volume":"6","author":"Chojnacki","year":"2020","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.3748\/wjg.v22.i12.3451","article-title":"Comparison of 5-hydroxytryptamine signalling pathway characteristics in diarrhea-predominant irritable bowel syndrome and ulcerative colitis","volume":"22","author":"You","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/apt.13459","article-title":"Alterations in serotonin metabolism in irritable bowel syndrome","volume":"43","author":"Thijssen","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1023\/A:1013256629600","article-title":"Impaired synthesis or cellular storage of norepinephrine, dopamine, and 5-hydroxytryptamine in human inflammatory bowel diseases","volume":"47","author":"Magro","year":"2002","journal-title":"Dig. Dis. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1523\/JNEUROSCI.4720-05.2006","article-title":"Physiological; modulation of intestinal motility by enteric dopaminergic neurons and D2 receptor: Analysis of dopamine receptor expression, location, development, and function in wild-type and knock-out mice","volume":"26","author":"Li","year":"2006","journal-title":"J. Neurosci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.brainres.2018.03.015","article-title":"Neurotransmitterrs modulation by the gut microbiota","volume":"1693","author":"Strandwitz","year":"2018","journal-title":"Brain Res."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Chen, M., Ruan, G., Chen, L., Ying, S., Li, G., Xu, F., Xiao, Z., Tian, Y., Lv, L., and Ping, Y. (2021). Naurotransmitters and Intestinal Interactions: Focus on the Microbiota-Gut-Brain Axis in Irritable Bowel Syndrome. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.817100"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Cao, H., Liu, X., Yingyong, A., Zhou, G., Liu, Y., Dong, W., Wang, S., Yan, F., Jiang, K., and Wang, B. (2017). Dysbiosis contributes to chronic constipation development via regulation of serotonin transporter in the intestine. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-10835-8"},{"key":"ref_16","first-page":"711","article-title":"Evaluation of serotonin and dopamine secretion and metabolism in patients with irritable bowel syndrome","volume":"128","author":"Chojnacki","year":"2018","journal-title":"Pol. Arch. Int. Med."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Chojnacki, J., Konrad, P., Medrek-Socha, M., Kaczka, A., B\u0142o\u0144ska, A., Zajdel, R., Chojnacki, M., and G\u0105siorowska, A. (2023). The Variablity of Tryptophan Metabolism in Patients with Mixed Type of Irritable Bowel Syndrome. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms25052550"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1177\/2050640619900577","article-title":"Discriminant and convergent validity of the GSRS-IBS symptom severity measure for irritable bowel syndrome: A population study","volume":"8","author":"Jones","year":"2020","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.14309\/ajg.0000000000000501","article-title":"ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth","volume":"115","author":"Pimentel","year":"2020","journal-title":"Am. J. Gastroenterol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/apt.13236","article-title":"Deviations in human gut microbiota: A novel diagnostic test for determining dysbiosis in patients with IBS or IBD","volume":"42","author":"Vebo","year":"2015","journal-title":"Alement. Pharmacol. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/j.gastro.2019.03.049","article-title":"Gut microbiota in Patients with Irritable Bowel Syndrome. A Systemic Review","volume":"157","author":"Pittayanon","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1053\/j.gastro.2019.11.301","article-title":"Differences in Fecal Microbiomes and Metabolomes of People With vs Without Irritable Bowel Syndrome and Bile Acid Malabsorption","volume":"158","author":"Jeffery","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Duan, R., Zhu, S., Wang, B., and Duan, L. (2019). Alterations of Gut Microbiota in Patients With Irritable Bowel Syndrome Based on 16S rRNA-Target Sequencing: A Systemic Review. Clin. Transl. Gastroenterol., 10.","DOI":"10.14309\/ctg.0000000000000012"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jand.2019.05.015","article-title":"Gut Microbial Dysbiosis in the Irritable Bowel Syndrome: A Systemic Review and Meta-Analysis of Case-Control Studies","volume":"120","author":"Wang","year":"2020","journal-title":"J. Acad. Nutr. Diet."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Zhuang, X., Tian, Z., Li, L., Chen, M., and Xiong, L. (2018). Fecal Microbiota Alterations Associated with Diarrhea-Predominant Irritable Bowel Syndrome. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.01600"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Caroll, I.M., Ringel-Kulka, T., Siddle, J.P., and Ringel, Y. (2012). Alterations in Composition and Diversity of the Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome. Neurogastroenterol. Motil., 24.","DOI":"10.1111\/j.1365-2982.2012.01891.x"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1007\/s10620-015-3607-y","article-title":"Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction. An Evidence of Dysbiosis","volume":"60","author":"Shukla","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.dld.2017.01.142","article-title":"Altered Molecular Signature of Intestinal Microbiota in Irritable Bowel Syndrome Patients Compared wih Healthy Controls: A systematic Review and Meta-Analysis","volume":"49","author":"Liu","year":"2017","journal-title":"Dig. Liver Dis."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Pozuelo, M., Panda, S., Santiago, A., Mendez, S., Accarino, A., Santos, J., Guarner, F., Azpiroz, F., and Manichanh, C. (2015). Reduction of Butyrate and Methane- Producing Microorganisms in Patients with Irritable Bowel Syndrome. Sci. Rep., 5.","DOI":"10.1038\/srep12693"},{"key":"ref_30","first-page":"1729","article-title":"Global and Deep Molecular Analysis of Microbiota Signatures in Fecal Samples from Patients with Irritable Bowel Syndrome","volume":"141","author":"Biagi","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2982.2011.01803.x","article-title":"Distinct Microbial Populations Exist in the Mucosa-Associated Microbiota of Sub-Groups of Irritable Bowel Syndrome: Distinct Mucosal Microbiota in IBS","volume":"24","author":"Parkes","year":"2012","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Chojnacki, J., Pop\u0142awski, T., Kaczka, A., Romanowska, N., Chojnacki, C., and G\u0105siorowska, A. (2024). Assessment of Urinary Dopamine and Serotonin Metabolites in Relation to Dysbiosis Indicators in Patients with Functional Constipation. Nutrients, 16.","DOI":"10.3390\/nu16172981"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.dld.2005.06.008","article-title":"Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation","volume":"37","author":"Khalif","year":"2005","journal-title":"Dig. Liver Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5056\/jnm14048","article-title":"Change of fecal flora and effectiveness of short-term VSL-3 probiotic treatment in patients with functional constipation","volume":"21","author":"Kim","year":"2015","journal-title":"J. Neurogastroenterol. Motil."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Mancabelli, L., Milani, C., Lugli, G.A., Turroni, F., Mangifest, M., Viappiani, A., Ticinesi, A., Nouvenne, A., Meschi, T., and Van Sinderen, D. (2017). Unvelling the gut microbiota composition and functionality associated with constipation trough metagenomic analyses. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-10663-w"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Pecyna, P., Gabyel, M., Mankowska-Wierzbicka, D., Nowak-Malczewska, D.M., Jaskiewicz, K., Jaworska, M.M., Tomczak, H., Rydzanicz, M., Ploski, R., and Grzymislawski, M. (2023). Gender Influences Gut Microbiota among Patients with Irritable Bowel Syndrome. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241310424"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Napolitano, M., Fasulo, E., Ungaro, F., Massimino, L., Sinagra, E., Danese, S., and Mandarino, F.V. (2023). Gut Dysbiosis in Irritable Bowel Syndrome: A Narrative Review on Correlation with Disease Subtypes and Novel Therapeutic Implications. Microorganisms, 11.","DOI":"10.3390\/microorganisms11102369"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2147\/CEG.S451675","article-title":"A Systemic Review: Fecal Bacterial Profile in Patients with Irritable Bowel Syndrome Analyzed with the GA-Map Dysbiosis Test Based on the 16S rRNA Gene of Bacterial Species or Groups","volume":"17","author":"Teige","year":"2024","journal-title":"Clin. Exper. Gastroenterol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1007\/s11136-023-03407-z","article-title":"Content validation of a daily patient-reported outcome measure for assessing symptoms in patients with Small Intestinal Bacterial Overgrowth","volume":"32","author":"Durgam","year":"2023","journal-title":"Qual. Life Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5056\/jnm19113","article-title":"Breath Tests for the Non-invasive Diagosis of Small Intestinal Bacterial Overgrowth. A systematic Review with Meta-analysis","volume":"26","author":"Losurdo","year":"2020","journal-title":"J. Neurogastroenterol. Motil."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/jgh3.12145","article-title":"Reevaluating our understanding of lactulose breath tests by incorporating hydrogen sulfide measurements","volume":"3","author":"Birg","year":"2019","journal-title":"JGH Open"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1080\/10408347.2016.1153949","article-title":"The Measurement of Ammonia in Human Breath and its Potential in Clinical Diagnostics","volume":"46","author":"Brannelly","year":"2016","journal-title":"Crit. Rev. Anal. Chem."},{"key":"ref_43","first-page":"110","article-title":"Bacterial urease\u2014A diagnostic marker or factor of enteric bacteria pathogenicity","volume":"60","author":"Furowicz","year":"2004","journal-title":"Med. Wet."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Ahluwalia, B., Iribarren, C., Magnusson, M.K., Sundin, J., Clevers, E., Savolainen, O., Ross, A.B., T\u00f6rnblom, H., Simr\u00e9n, M., and \u00d6hman, L. (2021). A Distinct Faecal Microbiota and Metabolite Profile Linked to Bowel Habits in Patients with Irritable Bowel Syndrome. Cells, 10.","DOI":"10.3390\/cells10061459"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.14336\/AD.2022.0104","article-title":"Functions of Gut Microbiota Metabolites, Current Status and Future Perspectives","volume":"13","author":"Liu","year":"2022","journal-title":"Aging Dis."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Conley, T.E., Slater, R., Moss, S., Bulmer, D.C., Revilla Negro, J., Ijaz, U.Z., Pritchard, D.M., Parkes, M., and Probert, C. (2024). Microbiome-driven IBS metabotypes influence response to he low FODMAP diet: Insights from the faecal volatome. EBioMedicine, 107.","DOI":"10.1016\/j.ebiom.2024.105282"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Hooks, K.B., and O\u2019Malley, M.A. (2017). Dysbiosis and Its Discontents. MBio, 8.","DOI":"10.1128\/mBio.01492-17"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Sun, W., Ding, D., Bai, D., Lin, Y., Zhang, C., and Zhang, D. (2023). Transcriptomics and metabolomics analysis of L-phenyloalanine overproduction in Escherichia coli. Microb. Cell Factories, 22.","DOI":"10.1186\/s12934-023-02070-w"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Roager, H.M., and Licht, T.R. (2018). Microbial tryptophan catabolites in health and disease. Nat. Commun., 9.","DOI":"10.1038\/s41467-018-05470-4"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/MED.0000000000000523","article-title":"Irritable bowel syndrome and gut microbiota","volume":"27","author":"Canakis","year":"2020","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2","DOI":"10.14218\/JTG.2023.00026","article-title":"Global Research Trends and Hot Spots in the Overlapping Fields of Functional Bowel Disorders and the Intestinal Microbiota: A Scientometric Analysis","volume":"1","author":"Jiang","year":"2023","journal-title":"J. Translat. Gastroenterol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Xiao, L., Liu, Q., Luo, M., and Xiong, L. (2021). Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome. Front. Cell. Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.729346"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Matsuura, N., Kanayama, M., Watanabe, Y., Yamada, H., Lili, L., and Torii, A. (2024). Effect of Personalize Prebiotic and Supplements on the Symptoms of Irritable Bowel Syndrome: An Open- Label, Single-Arm, Multicenter Clinical Trial. Nutrients, 16.","DOI":"10.3390\/nu16193333"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/13\/3\/652\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:48:39Z","timestamp":1760028519000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/13\/3\/652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":53,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["biomedicines13030652"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines13030652","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,7]]}}}